U.S. FDA Says Takeda Pharmaceutical Co. Ltd. Sleep Drug Promotion Misleads

Reuters -- Japan's Takeda Pharmaceutical Co (4502.T) used a misleading promotion for its insomnia drug Rozerem, U.S. regulators said in a letter released on Friday.

MORE ON THIS TOPIC